NCT07168668
- Conditions
- HCC, Immunotherapy, TACE
- Locations
-
Not specified
Clinical trial condition
Immunotherapy
Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.
219 public trials
107 recruiting studies
Immunotherapy trial results
NCT07715565
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- West China Hospital, Chengdu, Sichuan 610000 Chengdu, China
Not yet recruiting
QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer
NCT07617818
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
NCT07549906
- Conditions
- Beta Blocker, Colon Cancer (Stage II &Amp; III), Colonic Diseases, +12 more
- Locations
-
Not specified
Not yet recruiting
Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection
NCT07461675
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Geneva University Hospitals Geneva, Switzerland
Not yet recruiting
Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer
NCT07409844
- Conditions
- Colon Cancer Stage I, Colon Cancer Stage II/III, Colonic Diseases, +13 more
- Locations
-
- Zealand University Hospital Køge, Denmark
Not yet recruiting
Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)
NCT07396116
- Conditions
- Immunotherapy, Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Not yet recruiting
Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer
NCT07369986
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +13 more
- Locations
-
Not specified
NCT07266025
- Conditions
- Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Immunotherapy, +2 more
- Locations
-
Not specified
Not yet recruiting
Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma
NCT07259473
- Conditions
- Gastric / Gastroesophageal Junction Adenocarcinoma, Immunotherapy, Mismatch Repair Deficient or MSI-High Solid Tumors, +1 more
- Locations
-
Not specified